Koshland Pharm Funding: How Much Did They Raise & Key Investors

How Much Did Koshland Pharm Raise?
Funding & Key Investors

Koshland Pharm has successfully secured a significant capital injection, bringing its total valuation trajectory to $350K. This latest infusion of $350K represents a major strategic investment designed to fortify the company's operational infrastructure within the specialized pharmaceutical sector. By leveraging this financial backing, the organization is positioned to scale its bespoke medication services while maintaining the rigorous quality standards that define its market presence.

The recent financing round underscores investor confidence in the company's unique business model, which bridges the gap between traditional pharmacy services and personalized patient care. As the healthcare landscape shifts toward individualized treatment protocols, Koshland Pharm remains at the forefront of the compounding industry, utilizing this influx of resources to expand its reach and enhance its service delivery capabilities across California.

What is Koshland Pharm?

Koshland Pharm

Retail

Drug Stores & Pharmacies

Manufacturing

Koshland Pharm operates as a high-precision custom compounding pharmacy, distinguishing itself through the creation of personalized prescription medications tailored to specific patient requirements. By fostering collaborative relationships with healthcare providers and patients, the firm ensures that therapeutic outcomes are optimized through customized formulations. Beyond core compounding services, the company curates a selection of premium supplements and dermatological products, reinforcing its commitment to holistic health management. Its market position is anchored in the delivery of uncompromising product quality and a patient-centric experience, addressing complex health needs such as hormone replacement therapy and pediatric care with specialized expertise.

How much funding has Koshland Pharm raised?

Koshland Pharm has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in Koshland Pharm

PPP

Public-Private Partnership

What's next for Koshland Pharm?

With the successful acquisition of this late-stage capital, Koshland Pharm is poised to accelerate its growth strategy by optimizing its compounding facilities and expanding its digital patient engagement platforms. The strategic roadmap likely involves scaling production capacity to meet the rising demand for personalized medicine while investing in advanced quality control technologies to maintain its competitive edge. Furthermore, the company is expected to deepen its integration with regional healthcare networks, solidifying its role as a critical partner in the California medical ecosystem. By focusing on operational efficiency and market expansion, Koshland Pharm aims to leverage this investment to transition into a broader, more robust provider of specialized pharmaceutical solutions, ensuring long-term sustainability and continued innovation in the compounding space.

See full Koshland Pharm company page

See More Financial Insights